Acne vulgaris is a common chronic skin condition involving blockage and/or inflammation of the hair follicles and their accompanying sebaceous glands. Earlier this year, the US Food and Drug Administration (FDA) approved Epiduo Forte Gel—a topical gel combination of two antibiotic free medications—for the treatment of moderate to severe acne vulgaris.
In a double-blind study of 217 patients—half of whom had severe acne to start—more than half of the patients with acne saw a market improvement during the study, with some seeing results in as little as one week and continued improvement through the 12-week study.
“Acne is a challenging condition to manage. It can vary greatly from patient to patient, can have a significant physical and psychosocial impact on sufferers, and patients can find treatment adherence difficult to maintain,” Jonathan Weiss, MD, a board-certified dermatologist at Gwinnett Dermatology, PC, and lead investigator on the study, said in a news release.
“For many patients, rapid results are especially important, and some acne treatments take time to show effect. We were very excited to see in the clinical trial that people using Epiduo Forte gel saw results as early as 1 week, with efficacy continually improving through week 12,” Dr Weiss added.
Epiduo Forte Gel is the new product from Galderma Laboratories. This topical medication comes in a convenient and easy to use pump. The most common side effects of this medication are skin irritation, eczema, atopic dermatitis, and burning sensation on the skin.
Epiduo Forte Gel is now available by prescription. If you are a patient who suffers from acne, talk to your dermatologist for more information about Epiduo Forte Gel and know Rite Care is here for you to fill your prescriptions.
If you are a healthcare provider, Rite Care is your source across the nation for dermatological prescription medications.